Related Experiment Video
Updated: Aug 5, 2026
07:48
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Biomedical Research Integrity: Addressing Conflicts of Interest and Ethical Challenges in Clinical Trials
Ravindra Waykar1, Yogesh A Kulkarni2
1Department of Medical and Health Humanities, Caspersen School of Graduate Studies, Drew University, 36 Madison Ave, Madison, NJ 07940, United States.
Reviews on Recent Clinical Trials
|July 28, 2026
Summary
Conflicts of Interest (COI) in biomedical research threaten patient safety and research quality. Inconsistent policies and poor enforcement of COI disclosure requirements necessitate standardized management strategies.
Area of Science:
- Biomedical Research Ethics
- Conflict of Interest Management
- Research Integrity
Background:
- Conflicts of Interest (COI) are prevalent in biomedical research.
- High-profile cases reveal significant COI implications, including patient harm.
Purpose of the Study:
- To examine the prevalence and implications of COI in biomedical research.
- To analyze regulatory and ethical frameworks for COI management.
Main Methods:
- Review of high-profile COI cases (e.g., Troglitazone, Baselga, NIH, COX-2 inhibitors, Harvard psychiatrists, UK Universities).
- Analysis of existing COI management policies and disclosure requirements.
Main Results:
- COIs can compromise research quality and patient health, with extreme cases leading to fatalities.
- Inconsistent COI management policies, vague disclosure wording, and poor enforcement exacerbate the problem.
Conclusions:
- Consistent, standardized COI policies across fields are crucial.
- Academic journals should adopt uniform COI disclosure approaches.
- Policies must address overlooked areas like family financial interests and favor customized strategies.
Related Concept Videos
01:56Ethics in Research
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...